Cargando…
Role of once-daily glycopyrronium bromide (NVA237) in the management of COPD
Progressive airflow limitation is a hallmark feature of chronic obstructive pulmonary disease (COPD) that ultimately leads to breathlessness, impaired quality of life, and reduced exercise capacity. Pharmacotherapy is used in patients with COPD to prevent and control symptoms, reduce both the freque...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753168/ https://www.ncbi.nlm.nih.gov/pubmed/23990727 http://dx.doi.org/10.2147/TCRM.S30317 |